CCM
ZBH icon

Cadian Capital Management’s Zimmer Biomet ZBH Stock Holding History

Cadian Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-159,650
Closed -$16M – 48
2016
Q4 		$16M Buy
+159,650
New +$17.1M 0.85% 29
2014
Q1 		– Sell
-283,250
Closed -$25.6M – 105
2013
Q4 		$25.6M Buy
283,250
+25,750
+10% +$2.23M 0.66% 35
2013
Q3 		$20.5M Buy
+257,500
New +$20.3M 0.6% 42

Other funds holding ZBH

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cadian Capital Management's ZBH Position: Q1 2017 in Review

Cadian Capital Management sold out of Zimmer Biomet (ZBH) in Q1 2017, closing a stake of 159,650 shares — an estimated $16M sold.

Cadian Capital Management first reported a position in ZBH in Q3 2013 and held it in 3 quarters. The position peaked at $25.6M in Q4 2013. 817 funds tracked by Wall St. Rank hold ZBH as of Q1 2017.

  • Cadian Capital Management reported no remaining Zimmer Biomet position as of Q1 2017 after selling out during the quarter.
  • Cadian Capital Management sold 159,650 Zimmer Biomet shares in Q1 2017, an estimated $16M.
  • Cadian Capital Management first reported a position in Zimmer Biomet in Q3 2013 and held it in 3 quarters.
  • Cadian Capital Management's Zimmer Biomet position peaked at $25.6M in Q4 2013.
  • 817 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2017.

Based on Cadian Capital Management's 13F filing for Q1 2017, filed 12 May 2017.